Marc Scheineson comments on the Food and Drug Administration review of Phillip Morris’ modified risk tobacco product application for iQOS.
In the News
February 23, 2018
Inside Health Policy | American Cancer Society Calls for More Research on E-Cigarettes, New Tobacco Products
Media Contact